FDA

• Skip to main content
• Skip to FDA Search
• Skip to in this section menu
• Skip to footer links

Topic Paragraphs See Complete List of FDA Reforms

FDA Seizes 7-OH Opioids to Protect American Consumers

The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, announced today that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products—valued at roughly $1 million—from three firms in Missouri.

Read More

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

Report a Problem with an FDA Regulated Product

Dec 29

FDA Finds Insufficient Data to Determine Safety of PFAS in Cosmetic Products

Dec 19

FDA Grants Two National Priority Vouchers

More Press Announcements Newsroom Meetings Testimony Speeches

Jan 09

Modern Warrior Recalls “Modern Warrior Ready” Dietary Supplement Due to Undeclared 1,4-DMAA and Aniracetam, as Well as Tianeptine, Which has Not Been Approved for Supplement Use by the FDA.

Dietary Supplements, Drugs

Jan 09

HerbsForever LLC Issues Allergy Alert on Undeclared Wheat in HerbsForever brand Dietary Supplements

Food & Beverages

Jan 08

Gusto Group Inc. Recalls Shrimp Paste (Klong Kone) ‘'454 G. (1 LBS)’ and ‘910 G. (2 LBS)’ because of Possible Health Risk

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List Paragraph Header

FDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen

FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing.

FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity

The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.

FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program

ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making.

View More FDA Voices

Jan 06

Clinical Decision Support Software

Biologics, Drugs, Medical Devices

Jan 06

General Wellness: Policy for Low Risk Devices

Medical Devices

Dec 22

Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act

Drugs

FDA Guidance Search

Jobs at FDA

Inspections and Compliance

MedWatch: Safety Alerts

Science & Research

FDA Organization

Import Program

Warning Letters

Combination Products

Criminal Investigations

Disposal of Unused Medicines

Emergency Preparedness

Back to Top Feedback